Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Hepatitis C

  Free Subscription


07.04.2020

2 Am J Gastroenterol
1 Gut
3 J Hepatol
1 J Med Virol
1 J Viral Hepat
2 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. HUANG CF, Lai HC, Chen CY, Tseng KC, et al
    Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000606.
    PubMed         Abstract available

  2. KIDAMBI TD, Chu P, Lee JK, Lin JL, et al
    Immunotherapy-Associated Pseudomembranous Colitis.
    Am J Gastroenterol. 2019;114:1708.
    PubMed        


    Gut

  3. HUTCHINSON SJ, Valerio H, McDonald SA, Yeung A, et al
    Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study.
    Gut. 2020 Mar 26. pii: gutjnl-2019-320007. doi: 10.1136/gutjnl-2019-320007.
    PubMed         Abstract available


    J Hepatol

  4. BOON D, Bruce V, Patel EU, Quinn J, et al
    Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    J Hepatol. 2020 Mar 30. pii: S0168-8278(20)30190.
    PubMed         Abstract available

  5. SANGIOVANNI A, Alimenti E, Gattai R, Filomia R, et al
    Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
    J Hepatol. 2020 Mar 31. pii: S0168-8278(20)30192.
    PubMed         Abstract available

  6. VERNA EC, Morelli G, Terrault NA, Lok AS, et al
    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    J Hepatol. 2020 Mar 31. pii: S0168-8278(20)30193.
    PubMed         Abstract available


    J Med Virol

  7. JAMSHIDI S, Bokharaei-Salim F, Esghaei M, Bastani MN, et al
    Occult HCV and Occult HBV Co-infection in Iranian Human Immunodeficiency Virus-Infected Individuals.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25808.
    PubMed         Abstract available


    J Viral Hepat

  8. DESAI M, White E, Vora N, Gilson R, et al
    High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxis.
    J Viral Hepat. 2020 Apr 3. doi: 10.1111/jvh.13297.
    PubMed         Abstract available


    Transplant Proc

  9. CIECIURA T, Hryniewiecka E, Foroncewicz B, Strzelczyk Z, et al
    Long-Term Follow-up of Liver Transplant Recipients Treated With Direct-Acting Antiviral Agents for Hepatitis C Recurrence After Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31656.
    PubMed         Abstract available

  10. CIECIURA T, Urbanowicz A, Foroncewicz B, Hryniewiecka E, et al
    Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31659.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: